Decreased Expression of FADS1 Predicts a Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma

Authors:
  • SYShu-Mei Yan
    Shu-Mei Yan
  • WGWan-Yi Gu
    Wan-Yi Gu
  • FHFan He
    Fan He
  • LHLi-Yun Huang
    Li-Yun Huang
  • MLMei Li
    Mei Li
  • YYYan Yuan
    Yan Yuan
  • RCRen-Hui Chen
    Ren-Hui Chen
  • QZQian Zhong
    Qian Zhong
  • MLMan-Zhi Li
    Man-Zhi Li

Abstract
FADS1 (fatty acid desaturase 1) plays a crucial role in fatty acid metabolism, and it was recently reported to be involved in tumorigenesis. However, the role of FADS1 expression in esophageal squamous cell carcinoma (ESCC) remains unknown. In the current study, we investigated the expression and clinical pathologic and prognostic significance of FADS1 in ESCC. Immunohistochemical analyses revealed that 58.2% (146/251) of the ESCC tissues had low levels of FADS1 expression, whereas 41.8% (105/251) exhibited high levels of FADS1 expression. In positive cases, FADS1 expression was detected in the cytoplasm of cells. Correlation analyses demonstrated that FADS1 expression was significantly correlated with tumor location (p=0.025) but not with age, gender, histological grade, tumor status, nodal status or TNM staging. Furthermore, patients with tumors expressing high levels of FADS1had a longer disease-free survival time (p<0.001) and overall survival time (p<0.001). Univariate and multivariate analyses revealed that, along with nodal status, FADS1 expression was an independent and significant predictive factor (p<0.001). In conclusion, our study suggested that FADS1 might be a valuable biomarker and potential therapeutic target for ESCC.

This publication has 29 references indexed in Scilit: